Alexander K Bartella1, Sebastian Lemmen2, Aida Burnic3, Anita Kloss-Brandstätter3,4, Mohammad Kamal3, Thomas Breisach5, Frank Hölzle3, Bernd Lethaus3. 1. Department of Oral, Maxillofacial and Plastic Facial Surgery, University Hospital of Aachen University, Pauwelsstraße 30, 52074, Aachen, Germany. abartella@ukaachen.de. 2. Department of Infection Control and Infectious Diseases, University Hospital of Aachen University, Pauwelsstraße 30, 52074, Aachen, Germany. 3. Department of Oral, Maxillofacial and Plastic Facial Surgery, University Hospital of Aachen University, Pauwelsstraße 30, 52074, Aachen, Germany. 4. Carinthia University of Applied Sciences, Europastrasse 4, 9524, Villach, Austria. 5. Institute for Health and Social Issues, FOM University of Applied Sciences for Economics and Management in Munich, Arnulfstraße 30, 80335, Munich, Germany.
Abstract
PURPOSE: The adequate perioperative antibiotic prophylaxis in maxillofacial surgery is still under discussion due to the wide range of hard and soft tissue procedures as well as contaminated, semi-contaminated and clean surgical sides. Perioperative antibiosis is an easy applicable tool that can be used to decrease nosocomial morbidity and mortality by reducing the rate of infections. We compared strictly perioperative antibiosis with an extended postoperative prophylactic antibiosis. MATERIALS AND METHODS: In this study, 901 consecutive patients, from a tertiary care maxillofacial surgery department were included and distributed into two groups: The first group received peri- and postoperative antibiotic prophylaxis (PP; n = 365) from the day of operation until the fifth day postoperatively. The second group was treated with single shot prophylaxis with intraoperative repetition as needed (SSP; n = 536) only. Furthermore, the patients were grouped according to their main diagnosis and surgical procedure. For comparison, general anamnestic data, cultured bacteria and resistances, number of surgical site infections and duration of hospitalization were compared. RESULTS: There were no statistically significant differences in general diseases or extent of surgery between the groups. There was no statistical difference in the surgical site infections between the groups regardless of their diagnosis. There were significant correlations between tracheotomised patients (p < 0.001) as well as patients with a higher BMI (p = 0.009) and the incidence of surgical site infections. Most common cultured bacteria were staphylococci. CONCLUSION: Based on the findings of the study, we believe that a perioperative antibiosis delivers a sufficient prophylaxis for patients undergoing maxillofacial surgery procedures.
PURPOSE: The adequate perioperative antibiotic prophylaxis in maxillofacial surgery is still under discussion due to the wide range of hard and soft tissue procedures as well as contaminated, semi-contaminated and clean surgical sides. Perioperative antibiosis is an easy applicable tool that can be used to decrease nosocomial morbidity and mortality by reducing the rate of infections. We compared strictly perioperative antibiosis with an extended postoperative prophylactic antibiosis. MATERIALS AND METHODS: In this study, 901 consecutive patients, from a tertiary care maxillofacial surgery department were included and distributed into two groups: The first group received peri- and postoperative antibiotic prophylaxis (PP; n = 365) from the day of operation until the fifth day postoperatively. The second group was treated with single shot prophylaxis with intraoperative repetition as needed (SSP; n = 536) only. Furthermore, the patients were grouped according to their main diagnosis and surgical procedure. For comparison, general anamnestic data, cultured bacteria and resistances, number of surgical site infections and duration of hospitalization were compared. RESULTS: There were no statistically significant differences in general diseases or extent of surgery between the groups. There was no statistical difference in the surgical site infections between the groups regardless of their diagnosis. There were significant correlations between tracheotomised patients (p < 0.001) as well as patients with a higher BMI (p = 0.009) and the incidence of surgical site infections. Most common cultured bacteria were staphylococci. CONCLUSION: Based on the findings of the study, we believe that a perioperative antibiosis delivers a sufficient prophylaxis for patients undergoing maxillofacial surgery procedures.
Entities:
Keywords:
Antibiotic prophylaxis; Maxillofacial surgery; Nosocomial infection; Surgical site infections
Authors: Stephan Ariyan; Janet Martin; Avtar Lal; Davy Cheng; Gregory L Borah; Kevin C Chung; John Conly; Robert Havlik; W P Andrew Lee; Mary H McGrath; Julian Pribaz; V Leroy Young Journal: Plast Reconstr Surg Date: 2015-06 Impact factor: 4.730
Authors: Mohemmed N Khan; Jack Russo; John Spivack; Christopher Pool; Ilya Likhterov; Marita Teng; Eric M Genden; Brett A Miles Journal: JAMA Otolaryngol Head Neck Surg Date: 2017-06-01 Impact factor: 6.223
Authors: Joseph McDevitt; Marianna de Camargo Cancela; Maria Kelly; Harry Comber; Linda Sharp Journal: Oral Surg Oral Med Oral Pathol Oral Radiol Date: 2015-08-11
Authors: Ahmed Sam Beydoun; Kevin Koss; Tyson Nielsen; Andrew James Holcomb; Priscilla Pichardo; Nicholas Purdy; Aaron L Zebolsky; Chase M Heaton; Caitlin P McMullen; Jessica A Yesensky; Michael G Moore; Neerav Goyal; Joshua Kohan; Mirabelle Sajisevi; Kenneth Tan; Daniel Petrisor; Mark K Wax; Alexandra E Kejner; Zain Hassan; Skylar Trott; Andrew Larson; Jeremy D Richmon; Evan M Graboyes; C Burton Wood; Ryan S Jackson; Patrik Pipkorn; Jennifer Bruening; Becky Massey; Sidharth V Puram; Joseph Zenga Journal: JAMA Otolaryngol Head Neck Surg Date: 2022-06-01 Impact factor: 8.961
Authors: Michael M Lindeborg; Rosh K V Sethi; Sidharth V Puram; Anuraag Parikh; Bharat Yarlagadda; Mark Varvares; Kevin Emerick; Derrick Lin; Marlene L Durand; Daniel G Deschler Journal: Laryngoscope Investig Otolaryngol Date: 2020-05-28
Authors: Elizabeth E Mmari; Eunice S Pallangyo; Athar Ali; Dereck A Kaale; Isaac H Mawalla; Muzdalifat S Abeid Journal: PLoS One Date: 2021-08-26 Impact factor: 3.240
Authors: Vincent Vander Poorten; Saartje Uyttebroek; K Thomas Robbins; Juan P Rodrigo; Remco de Bree; Annouschka Laenen; Nabil F Saba; Carlos Suarez; Antti Mäkitie; Alessandra Rinaldo; Alfio Ferlito Journal: Adv Ther Date: 2020-03-05 Impact factor: 3.845